In Brief:
In this Peruvian descriptive study, among the 165 Neisseria gonorrhoeae isolates collected between 2018 and 2019, 95.2% were resistant to fluoroquinolones; in addition, 1.2% and 3.6% of the isolates showed reduced susceptibility to ceftriaxone and cefixime, respectively.